Nature Communications (Aug 2022)
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Abstract
Next-generation lipid nanoparticles that target non-hepatocytes could be important clinical tools. Using in vivo DNA barcoding, the authors identify piperazine-containing lipids deliver mRNA to immune cells without targeting ligands.